期刊文献+

雌激素对帕金森病保护作用的实验研究 被引量:4

Experimental Study on the Protective Effect of Estrogen to Parkinson Disease
下载PDF
导出
摘要 目的 探讨雌激素对帕金森病是否具有保护作用。方法 利用免疫组化染色(ABC)法计数酪氨酸羟化酶(TH)的阳性细胞数,用TUNEL法观察每视野下凋亡细胞的数目,比较各组的差异。结果 正常雌性小鼠造模(A)组比去势后造模(B)组中只给予生理盐水(B1)组、造模后去势(C)组中只给予生理盐水(C1)组的TH阳性细胞数目多,凋亡细胞数目少(P<0.05);B1组与C1组差异无显著性(P>0.05);B2组(B组中给予雌激素组)比B1组及C2组(C组中给予雌激素组)比C1组FH阳性细胞多,凋亡细胞数目少(P<0.05)。结论 雌激素对帕金森病具有保护作用和损伤修复作用,且与凋亡有关。 Objective To explore if estrogen could provide protective effect of Parkinson disease, and the relationship between estrogen protective effect and apoptosis of nigral neurons of mouse. Methods Using im-raunohistochemical method of avidinbiotin peroxidase complex (ABC), we observed distribution of positive cells of tyrosine hydroxylase (TH)-positive cells and fibres in the substantia nigra of the mouse. Using TUNEL we observed the number of apoptosis cell in every visual field, obtain the difference between the test group and controls. Results The number of positive cells of TH was larger and the number of apoptosis cells was smaller in the normal-female-mouse models group than in the group of making model after ovariosteresis and the group of making model before ovariosteresis( P <0. 05); respectively, in each group, the results was simillar between the group given estrogen and the controls. Conclusions Our study suggest that estrogen may have protective effect on the nigral neurons of Parkinson disease. What more, the protective effect might be associated with the apoptosis.
出处 《中国神经免疫学和神经病学杂志》 CAS 2003年第4期254-257,F002,共5页 Chinese Journal of Neuroimmunology and Neurology
关键词 雌激素 帕金森病 动物实验 免疫组化染色 TUNEL法 细胞凋亡 运动障碍性疾病 Parkinson disease estrogen protection apoptosis
  • 相关文献

参考文献9

  • 1Heikkila RE, Hess A, Duvoisin RC. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice [J]. Science, 1984, 224: 1451-1453.
  • 2Arai N,Misugi K,Goshima Y, et al. Evaluation-of-1-methyl-4-phenyl- 1,2,3,6-tetahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism[J].Brain Res, 1990,515(1-2) :57-63.
  • 3Green PS, Simpkins JW. Neroprotective effects of estrogens: potential mechanlsmsof action [J]. Int JDev Neurosci, 2000,18(4-5) : 347-358.
  • 4Miller DB,AliSF,O'Callaghan JP, et al. The impact of gender and estrogen on striatal dopaminergic neurotoxicity[J]. Ann N Y Acad Sci, 1998,844: 153-165.
  • 5Sawada H, Shimobama S. Neuroprotective effects of estradiol in mesencephalic dopaminergic neuron[J].Neurosci Biobehav Rev, 2000,24(1):143-147.
  • 6Sawada H, Ibi H, Kihara T, et al. Estradiol protects mesencephalic dopaminergic neurons from-oxedative-stress-induced-neuronal-death [ J ]. Neurosci Res,1998,1 : 54 (5) : 707 -719.
  • 7Sayre LM. Biochemical mechenism of the dopaminergic neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahy-dropyridine(MPTP)[J]. Toxicol Lett, 1989,48(2):121-149.
  • 8Sawai H, Okazaki T, Yamamoto H, et al. Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells[J]. J Biol chem, 1995,270:27326-27331.
  • 9Kasibhatla S, Brunner T, Genstier L, et al. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T-lymphocytes via the activation of NF-κB and AP-1[J]. Mol Cell, 1998, 1(4) :543-551.

同被引文献35

  • 1么晓轶,李颖.植物雌激素对去势雌性大鼠缺血性脑损伤的神经保护作用[J].中国神经免疫学和神经病学杂志,2005,12(3):160-163. 被引量:15
  • 2Ziaei S,Moghasemi M, Faghihzadeh S. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women. Climacteric, 2010,13:147-156.
  • 3Nijland EA,Weijmar Schultz WC, Nathorst-Boos J, et al. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women= results of a randomized active- controlled trial. J SexMed,2008,5:646-656.
  • 4Keramaris NC, Clnristodou},akos GE, Lambrinoudaki IV, et al. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women. Climacteric, 2007,10:400-407.
  • 5Ueng J, Douketis JD. Prevention and treatment of hormone associated venous thromboembolism: a patient management approach. Hematol Oncol Clin North Am,2010,24:683-694.
  • 6Campisi R, Marengo FD. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Cardiovasc Drug Rev,2007,25 : 132-145.
  • 7Cicinelli E, Ranieri G, Mallei S, et al. Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E selectin in postmenopausal women. Fertil Steril,2006,86 :899-904.
  • 8Sator K, Sator MO, Sator PG, et al. Effects of tibolone on selectins in postmenopausal women. Maturitas,2006,53 : 166-170.
  • 9von Eekardstein A, Crook D, Elbers J, et al. Tiholone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux. Clin Endocrinol ( Oxf), 2003,58:49-58.
  • 10Campisi R, Marengo FD. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Cardiovasc Drug Rev, 2007,25 : 132-145.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部